-
C357116-25mgCelgosivir is an α-glucosidase I inhibitor that can be studied for its potential use in the treatment of HCV infection.
-
C357116-5mgCelgosivir is an α-glucosidase I inhibitor that can be studied for its potential use in the treatment of HCV infection.
-
C329353-25mgCellocidin is a small neutral alkyne produced by a number of Streptomyces species, first discovered by Suzuki and colleagues in 1958. Cellocidin has a broad antibacterial, antifungal and antitumor profile due to its ability to react with endogenous
-
C329353-5mgCellocidin is a small neutral alkyne produced by a number of Streptomyces species, first discovered by Suzuki and colleagues in 1958. Cellocidin has a broad antibacterial, antifungal and antitumor profile due to its ability to react with endogenous
-
C648634-10mgCephaloridine hydrate is a broad-spectrum antibacterial antibiotic. Cephaloridine has certain dose-related nephrotoxicity.In VitroCephaloridine hydrate can inhibit Staphylococcus aureus penicillin-sensitive strains, penicillin-resistant strains,
-
C648634-5mgCephaloridine hydrate is a broad-spectrum antibacterial antibiotic. Cephaloridine has certain dose-related nephrotoxicity.In VitroCephaloridine hydrate can inhibit Staphylococcus aureus penicillin-sensitive strains, penicillin-resistant strains,
-
C337167-25gCephalosporin C zinc salt is an antibiotic used to study the effect of transpeptidase expression, binding, and inhibition on bacterial cell wall mucopeptide synthesis. Cephalosporin C zinc salt, as is expected of a Cephalosporin, will disrupt the
-
C337167-5gCephalosporin C zinc salt is an antibiotic used to study the effect of transpeptidase expression, binding, and inhibition on bacterial cell wall mucopeptide synthesis. Cephalosporin C zinc salt, as is expected of a Cephalosporin, will disrupt the
-
-
-
-